ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report.
Laura Pardo GambarteAída Franganillo SuárezJavier Cornago NavascuésCarlos Soto de OzaetaCarlos Blas LópezMireia Atance PasarisasRocío Nieves Salgado SánchezCristina Serrano Del CastilloRaquel Mata SernaDiego Velasco RodríguezJosé Luis López-LorenzoPilar Llamas-SilleroLaura SolánPublished in: Medicina (Kaunas, Lithuania) (2022)
) during the first three days, our patient did not achieve complete remission (CR) until scheduled 3 + 7 regimen combined with ATRA treatment was established. This observation suggests that ATRA may be partially effective in some ZBTB16-RARA APLs.